Neurological involvement in Lyme disease has been reported to include meningitis, cranial neuropathy and radiculoneuritis. While it is known that in some cases of asceptic meningitis patients may develop hyperosmia, the association between hyperosmia and Lyme disease has not previously been studied. Objective: To carry out the first systematic study to ascertain whether hyperosmia is also a feature of Lyme disease. Method: A questionnaire regarding abnormal sensory sensitivity in respect of the sense of smell was administered to 16 serologically positive Lyme disease patients and to 18 control subjects. Results: The two groups were matched in respect of age, sex and body mass. None of the 34 subjects was suffering from migraine. Eight (50%) of the Lyme patients and none (0%) of the controls suffered from hyperosmia (p=0.0007). Conclusion: This first systematic controlled study showed that Lyme disease is associated with hyperosmia.
Olfaction is still poorly understood in humans; the main disorder of olfaction is anosmia or loss of the sense of smell 1 
.
Patients with hyperosmia complain of having an increased sensitivity of the sense of smell.
Lyme disease (also known as Lyme borreliosis) is a systemic arthropod-borne zoonosis caused by Borrelia spirochaetes, the incidence of which has recently been increasing with the geographical spread of infected ticks. It is well established that the bacteria can invade the skin (causing erythema migrans), musculoskeletal system (giving rise to Lyme arthritis), cardiovascular system (causing Lyme carditis) and the nervous system (Lyme neuroborreliosis), which may be associated with neuropsychiatric symptomatology 2 . In particular, neurological involvement in Lyme disease has been reported to include meningitis, cranial neuropathy and radiculoneuritis. It is known that in some cases of asceptic meningitis patients may develop hyperosmia 3 . However, to date, there have been no published studies regarding the relationship between Lyme disease and hyperosmia.
Therefore, the objective was to carry out the first systematic study to ascertain whether hyperosmia is a feature of Lyme disease.
METHOD Subjects
This study was cross-sectional. Serologically positive Lyme disease patients attending the neuroscience department were included in the study if they were aged 18 years or over, but excluded from the study if they were suffering from migraine or if they had suffered olfactory lesions.
Written informed consent was obtained and the AONM research ethics committee approved the study under protocol number 003-2012. All participants signed an informed consent form before taking part in this study. The study was carried out in accordance with the Declaration of Helsinki.
Procedures
The date of birth, sex, body mass and past medical history of each subject were recorded. Each subject was asked whether or not he or she was unduly sensitive to odours.
Statistical analysis
Continuous variables for which data which did not differ significantly from normality and for which the two groups did not have significantly different variances were compared between the Lyme disease and control groups using independent samples t-tests (equal variances), while discrete nominal variables were compared between groups using Fisher's exact probability test. All tests were two-tailed.
The software package used for the statistical analyses was IBM SPSS Statistics for Windows, Version 21.0.0.0 (64-bit edition) (IBM Corp, Armonk, NY, USA).
RESULTS
Sixteen serologically positive Lyme disease patients and 18 control subjects were studied. The two groups were matched in respect of mean age, sex ratio and mean body mass, as shown in Table. Eight (50%) of the Lyme disease patients and none (0%) of the controls suffered from hyperosmia (Fisher's exact probability test, p=0.0007).
DISCUSSION
This first systematic controlled study showed that Lyme disease is associated with hyperosmia. In the sample studied, there was a highly significant prevalence of hyperosmia in Lyme disease of 50%.
Known migraineurs were excluded from this study and so it is unlikely that migraine could account for our finding. Again, as none of the subjects included in the study had clinical signs of meningitis, it is unlikely that meningitis could account for the high prevalence of hyperosmia in the Lyme disease group, although a subclinical form of meningitis associated with Lyme borreliosis cannot be ruled out as of importance. Finally, it should be noted that none of the medication taken by any of the patients is known to be associated with hyperosmia. This is the first study of hyperosmia in Lyme disease. The high prevalence of this olfactory disorder found in our study suggests the need for further studies of olfactory function in this disease. It would also be of interest to carry out longitudinal studies to evaluate the response of hyperosmia to antibiotic pharmacotherapy. 
